Examining the Effects of Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes.

PreDiabetes Clinical Trial

Official title: Vivo Prediabetes Study: Evaluating the Effect of Participating in Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes

Status Not yet recruiting

Clinical Trial Summary

This is a 12-week randomized, controlled trial that seeks to examine the effect of Vivo on 1) change in lower extremity strength defined as number of chair stands done in 30 seconds and 2) change in average glycemic level (HbA1c) compared to a wait list control.

Clinical Trial Description

This is a 12-week randomized, controlled trial that seeks to examine the effect of Vivo on 1) change in lower extremity strength defined as number of chair stands done in 30 seconds and 2) change in average glycemic level (HbA1c) compared to a wait list control. After informed consent and baseline assessments, up to 90 individuals will be randomized in one of two arms: 1) Vivo intervention or 2) waitlist control. Participants in the Vivo 2.0 intervention arm will meet virtually twice a week with their small group and certified trainer for 45 minutes over a 12-week period. Participants will be men and women, ≥60 years old, sedentary, with prediabetes and low function. All participants will undergo baseline and 12-week assessments ;

Related Conditions & MeSH terms

• Glucose Intolerance
• Muscle Loss
• Muscle Weakness
• Older Adult
• PreDiabetes
• Prediabetic State

• NCT number: NCT06458530
• Study type: Interventional
• Source: Impactiv, Inc.
• Contact: Recruiter
• Phone: 919-660-7507
• Email: VivoPrediabetes@duke.edu
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 31, 2024
• Completion date: July 31, 2025